Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Agios Pharmaceuticals
Biotech
Agios' next-up PK med quelled transfusion need in some patients
Agios' plans for a second approved product beyond Pyrukynd are continuing apace after new proof-of-concept data for AG-946.
Max Bayer
Nov 20, 2023 11:24am
Agios pays $17.5M for Alnylam's siRNA blood disease program
Aug 3, 2023 8:40am
Servier’s $1.8B bet on Agios delivers phase 3 brain tumor win
Mar 14, 2023 10:15am
How 2 biotechs survived 2022’s stormy seas, per their CEOs
Jan 18, 2023 10:00am
Roche taps new North American diagnostics chief—Chutes & Ladders
Dec 9, 2022 9:30am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
